FOXL2 and blepharophimosis, ptosis, and epicanthus inversus syndrome: Therefore, identifying novel FOXL2 variants and improving the understanding of the role of mutations in the pathogenesis of BPES may lead to the determination of biomarkers for early BPES detection and provide treatment targets for intervention.